1 Comment

27 ANEMIA AND POLYCYTHEMIA

27 ANEMIA AND POLYCYTHEMIA
Harrison’s Manual of Medicine

27

ANEMIA AND POLYCYTHEMIA

Anemia
Polycythemia (Erythrocytosis)
Bibliography

ANEMIA
Anemia is defined as blood hemoglobin (Hb) concentration <140 g/L (<14 g/dL) or hematocrit (Hct) <42% in adult males; Hb <120 g/L (<12 g/dL) or Hct <37% in adult females.
Signs and symptoms of anemia are varied, depending on the level of anemia and the time course over which it developed. Acute anemia is nearly always due to blood loss or hemolysis. In acute blood loss, hypovolemia dominates the clinical picture; hypotension and decreased organ perfusion are the main issues. Symptoms associated with more chronic onset vary with the age of the pt and the adequacy of blood supply to critical organs. Moderate anemia is associated with fatigue, loss of stamina, breathlessness, and tachycardia. The pt’s skin and mucous membranes may appear pale. If the palmar creases are lighter in color than the surrounding skin with the fingers extended, Hb level is often <80 g/L (8 g/dL). In pts with coronary artery disease, anginal episodes may appear or increase in frequency and severity. In pts with carotid artery disease, lightheadedness or dizziness may develop.
A physiologic approach to anemia diagnosis is based on the understanding that a decrease in circulating red blood cells (RBC) can be related to either inadequate production of RBCs or increased RBC destruction or loss. Within the category of inadequate production, erythropoiesis can be either ineffective, due to an erythrocyte maturation defect (which usually results in RBCs that are too small or too large), or hypoproliferative (which usually results in RBCs of normal size, but too few of them).
Basic evaluations include: (1) reticulocyte index (RI), (2) review of blood smear and RBC indices [particularly mean corpuscular volume (MCV)] (Fig. 27-1).

FIGURE 27-1. The physiologic classification of anemia. CBC, complete blood count.

The RI is a measure of RBC production. The reticulocyte count is corrected for the Hct level and for early release of marrow reticulocytes into the circulation, which leads to an increase in the life span of the circulating reticulocyte beyond the usual 1 day. Thus, RI = (% reticulocytes × pt Hct/45%) × (1/shift correction factor). The shift correction factor varies with the Hct: 1.5 for Hct = 35%, 2 for Hct = 25%, 2.5 for Hct = 15%. RI < 2–2.5% implies inadequate RBC production for the particular level of anemia; RI > 2.5% implies excessive RBC destruction or loss.
If the anemia is associated with a low RI, RBC morphology helps distinguish a maturation disorder from hypoproliferative marrow states. Cytoplasmic maturation defects such as iron deficiency or Hb synthesis problems produce smaller RBCs, MCV <80; nuclear maturation defects such as B12 and folate deficiency and drug effects produce larger RBCs, MCV >100. In hypoproliferative marrow states, RBCs are generally normal in morphology but too few are produced. Bone marrow examination is often helpful in the evaluation of anemia but is done most frequently to diagnose hypoproliferative marrow states.
Other laboratory tests indicated to evaluate particular forms of anemia depend on the initial classification based on the pathophysiology of the defect. These are discussed in more detail in chap.58.
POLYCYTHEMIA (ERYTHROCYTOSIS)
This is an increase above the normal range of RBCs in the circulation. Concern that the Hb level may be abnormally high should be triggered at a level of 170 g/L (17 g/dL) in men and 150 g/L (15 g/dL) in women. Polycythemia is usually found incidentally at routine blood count. Relative erythrocytosis, due to plasma volume loss (e.g., severe dehydration, burns), does not represent a true increase in total RBC mass. Absolute erythrocytosis is a true increase in total RBC mass.
CAUSES   Polycythemia vera (a clonal myeloproliferative disorder), erythropoietin-producing neoplasms (e.g., renal cancer, cerebellar hemangioma), chronic hypoxemia (e.g., high altitude, pulmonary disease), carboxyhemoglobin excess (e.g., smokers), high-affinity hemoglobin variants, Cushing’s syndrome, androgen excess. Polycythemia vera is distinguished from secondary polycythemia by the presence of splenomegaly, leukocytosis, thrombocytosis, and elevated vitamin B12 levels, and by decreased erythropoietin levels. An approach to evaluate polycythemic pts is shown in Fig. 27-2.

FIGURE 27-2. An approach to diagnosing patients with polycythemia. RBC, red blood cell; EPO, erythropoietin; COPD, chronic obstructive pulmonary disease; AV, atrioventricular; IVP, intravenous pyelogram; CT, computed tomography.

COMPLICATIONS   Hyperviscosity (with diminished O2 delivery) with risk of ischemic organ injury and thrombosis (venous or arterial) are most common.

TREATMENT
Phlebotomy recommended for Hct ³ 55%, regardless of cause, to low-normal range.

Bibliography

For a more detailed discussion, see Adamson JW, Longo DL: Anemia and Polycythemia, Chap. 61, p. 348, in HPIM-15.

Advertisements

One comment on “27 ANEMIA AND POLYCYTHEMIA

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: